Hydroxyprogesterone caproate therapy in advanced endometrial cancer.
D000230:Adenocarcinoma / Q000188:drug therapy* / Q000401:mortality; D000328:Adult; D000367:Age Factors; D000368:Aged; D002208:Caproates / Q000008:administration & dosage / Q000009:adverse effects; D004717:Endometrium; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006908:Hydroxyprogesterones / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D007267:Injections; D008875:Middle Aged; D002583:Uterine Cervical Neoplasms / Q000188:drug therapy; D014594:Uterine Neoplasms / Q000188:drug therapy*
D002208:Caproates; D006908:Hydroxyprogesterones